Navigation Links
Sosei Announces Start of AD 923 Phase III Studies in Europe
Date:2/11/2008

TOKYO, Japan, February 12 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), a biopharmaceutical company, today announces that it has commenced Phase III studies for its fentanyl sublingual spray (AD 923), an opioid analgesic for the treatment of cancer breakthrough pain.

The trial is a multi-centre, randomised, double-blind, double-dummy, crossover study to evaluate the safety and efficacy of AD 923 against an active comparator (morphine sulphate immediate release (MSIR)) for the treatment of breakthrough pain in patients with malignancies. The primary endpoint is the well established summary of pain intensity difference (SPID) measure over the first 30 minutes from initial dosing.

Overall, the European Phase III programme will involve some 300 patients in two studies, involving an active comparator, across 10 European countries. These will then be followed by a single combined open label study to assess the long term effectiveness, safety and tolerability of AD 923.

In June 2006, Sosei entered into an agreement with Mundipharma International Corporation Limited for the development and commercialisation of AD 923 in Europe and other international markets, excluding North America and Japan. Sosei is currently evaluating its commercialisation options for the un-partnered territories.

Mr Shinichi Tamura, President & CEO of Sosei, said: "I am delighted that we are able to announce the start of Phase III studies. AD 923 has been optimised to meet the well recognised need for a safe and effective method of delivering fentanyl for the rapid relief of breakthrough pain in malignant and also non-malignant conditions."

Notes for Editors:

About Sosei

Sosei Group Corporation is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for establish
'/>"/>

SOURCE Sosei Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD
2. Sosei Announces Update on Phase I Trials for SD118
3. Sosei Announces Approval to Start AD 923 Phase III Studies in Europe
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... ... Amada Senior Care, premier provider of in-home care and assisted living placement ... location. Amada franchise partners Mike and Mell Fleming came to the senior care industry ... years in medical device sales while Mell spent over 30 years as a registered ...
(Date:9/2/2015)... ... September 02, 2015 , ... SonicSurg ... extremity surgical market, announced today that more than 600 successful patient procedures have ... hand. Plus, nearly 70 of these procedures have been on triggering thumbs. ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... records and case management solutions and services to both government and commercial clients, ... and Image Clean-up utility for IBM’s Datacap document capture platform. EDAC PurePAGE ...
(Date:9/2/2015)... ... September 02, 2015 , ... On September 9, 2015, ... doTERRA’s annual convention, the largest single-company convention to date for the state of Utah. ... forward to a tremendous event,” states David Stirling, doTERRA CEO. “One of the most ...
(Date:9/2/2015)... ... September 02, 2015 , ... “ G-Hold ” was featured ... coolest technology products available to consumers. Amanda Forstrom, a technology expert and special reporter ... for people to comfortably hold a tablet while reducing the likelihood of it dropping. ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2
... Democratic leadership and State delegations as a possible solution to national ... ... 29, 2008 -- If there has been any one consistent message ... been the party platform initiative to resolve our national health care ...
... online financial planning calculators available to people with disabilities. , ... ... to move forward after a diagnosis of a long-term disability is ... as they can to understand their financial options, according to ...
... and local government clients to engage via GSA. , ... ... emerging software engineering firm dedicated to the life sciences, announced ... GSA IT Schedule 70 provides government customers with the ability to ...
... found , , THURSDAY, Aug. 28 (HealthDay News) -- Working ... for people who have survived a stroke and gone ... , "You address two problems these patients have," said ... neurology and neurorehabilitation at the University of Zurich in ...
... VIEW, Calif., Aug. 28 The 2008 European,Hemodialysis Emerging ... in recognition of its pioneering Redsense -- a unique ... during hemodialysis,and may save the lives of many patients"., ... sensor patch. The sensor is,connected to the alarm using ...
... Aug. 28 ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA ... Thomas Weisel,Partners Healthcare Conference at 11:30 a.m. Eastern ... Seasons Hotel in Boston, MA., ISTA,s President ... provide an update on the Company,s commercial and ...
Cached Medicine News:Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Treadmill Workouts Help Stroke Survivors 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3
(Date:9/2/2015)... 2015  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... has entered into a definitive agreement under which Valeant ... (NASDAQ: SURG ) for $6.50 per share in ... stockholders will receive additional cash payments of up to ... following the closing.  The transaction is expected to close ...
(Date:9/2/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD; RLMDD), a clinical-stage ... pain, announced today that the company,s management will be ... Healthcare Conference and BioCentury NewsMakers Conference.  Details of the ... Healthcare Conference Date:  Wednesday, September 9 Location: ... presentation, investor meetings only BioCentury NewsMakers Conference ...
(Date:9/2/2015)... 2015 Tumultuous market conditions – including changes ... M&A activity – have led more than half of ... sales reps. This marks the first time that the ... halfway point, according to the spring 2015 AccessMonitor™ ... ZS . AccessMonitor™ aggregates sales-call ...
Breaking Medicine Technology:Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5
... N.J., Oct. 27 Savient Pharmaceuticals, Inc. (Nasdaq: ... results for the third quarter 2010 following the close of ... Paul Hamelin, President, and David Gionco, Group Vice President, Chief ... call beginning at 9:00 a.m. Eastern Time on Friday, November ...
... 27 Express Scripts, Inc. (Nasdaq: ESRX ) announced ... or $0.57 per diluted share.  Third quarter adjusted earnings per share, ... increase of 55% over 2009. Third Quarter ... Tables 2 and 3) Total adjusted claims of ...
Cached Medicine Technology:Savient Pharmaceuticals to Hold Third Quarter 2010 Financial Results Conference Call on Friday, November 5, 2010 2Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 2Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 3Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 4Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 5Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 6Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 7Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 8Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 9Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 10Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 11Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 12Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 13Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 14Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 15Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 16
... Vascular Graft, the newest vascular graft offering ... leader in vascular surgical products for more ... reducing kinking and compression problems that ... graft provides all of the benefits of ...
... rasping necessary in cruciate ligament reconstruction procedures ... bone surface. This condition, if not rectified ... cruciate replacement. The GORE SMOOTHER Crucial Tool ... procedures. The tool functions as both a ...
Vikingselect™ Intra-Operative Monitoring (IOM)....
... system has been designed by practicing ... of the ever changing and demanding ... analyzing data from multiple modalities, including: ... and multiple patients at multiple sites. ...
Medicine Products: